Ambient particulate matter, C-reactive protein, and coronary artery disease

Inhalation Toxicology

Volumn 17, Issue 7-8, 2005, Pages 409-413

  Sandhu, Ripple S ^a   Petroni, Daniel H ^a   George, William J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AIR POLLUTION; ATHEROGENESIS; CORONARY ARTERY DISEASE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LUNG ALVEOLUS MACROPHAGE; MORBIDITY; MORTALITY; PARTICULATE MATTER; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AIR POLLUTANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; ENVIRONMENTAL EXPOSURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PARTICLE SIZE; RISK FACTORS;

EID: 21344440023     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370590929538     Document Type: Review

References (52)

1. AFCAPS/TexCAPS. 1998. Air Force/Texas Cornary Atherosclerosis Prevention Study. J. Am. Med. Assoc. 279:1615-1622.
2. American Heart Association. 1997. American Heart Association scientific statement: Aspirin as a therapeutic agent in cardiovascular disease. Circulation 2751-2753.
3. Bustos, C., Hernandez-Presa, M., Onega, M., Tunon, J., Orterga, L., Perez, F., Diaz, C., Hernandez, G., and Egido, J. 1998. HMG-CoA reductase inhibition reduces neointimal inflammation in a rabbit model of atherosclerosis. J. Am. Coll. Cardiol. 32:2057-2064.
4. Chan, A., Bhatt, D., Chew, D., Reginelli, J., Schneider, J., Topol, E., and Ellis, S. 2003. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 107:1750-1756.
5. Chew, D., Bhatt, D., and Robbins, M. 2001. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104:992-997.
6. Dockery, D., Pope, A., and Xu, X. 1993. An association between air pollution and mortality in six U.S. cities. N. Engl. J. Med. 329:1753-1759.
7. Dockery, D. 2001. Epidemiological evidence of cardiovascular effects of particulate air pollution. Environ. Health Perspect. 109(suppl. 4): 483-486.
8. Donaldson, K., Stone, V., Seaton, A., and MacNee, W. 2001. Ambient particle inhalation and the cardiovascular system: Potential mechanisms. Environ. Health Perspect. 109(suppl. 4):523-527.
9. Downs, J., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorter, A., Stein, E. A., Kruyer, W., and Gotto, A. M. Jr. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS Air Force/Texas Coronary Atheriosclerosis Prevention Study. JAMA 279(20):1619-1622.
10. Driscoll, K., Carter, J., Hassenbein, D., and Howard, B. 1997. Cytokines and particle-induced inflammatory cell recruitment. Environ. Health Perspect. 105(suppl. 5):1159-1164.
11. Fichtischerer, S., Rosenberger, G., Walter, D., Breurer, S., Dimmler, S., and Zeiher, A. 2000. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102:1000-1006.
12. Fu, T., and Borensztajn, J. 2002. Macrophage uptake of LDL bound to aggregated C-reactive protein: Possible mechanism of foam cell formation in atherosclerotic lesions. Biochem. J. 366:195-201.
13. Fukumoto, Y., Libby, P., Rabkin, E., Hill, C., Enomoto, M., Hirouchi, Y., Shiomi, M., and Aikawa, M. 2001. Statins alter smooth muscle cell accumulation and collagen content on established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation 103:993.
14. Gabay, C., and Kushner, I. 1999. Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation. N. Eng. J. Med. 340:448-454.
15. Goldberg, M., Burnett, R., Bailar, J., Brook, J., Bonvolant, Y., Tamblyn, R., Singh, R., and Vincent, R. 2001. The association between daily mortality and ambient air particle pollution in Montreal, Quebec. Environ. Res. 86:26-36.
16. Goldeski, J., Verrier, R., and Koutrakis, P. 2000. Mechanisms of morbidity and mortality from exposure to ambient air particles. Respir. Reprod. Health Effects Inst. 91:5-88.
17. Gotschlich, E., and Stetson, C. 1960. Immunologic cross-reactions among mammalian acute phase proteins. J. Exp. Med. 11:141-145.
18. Gu, L., Okada, Y., and Clinton, S. 1998. Absence of monocyte chemoattractant protein-1 reduced atherosclerosis in low-density lipoprotein-deficient mice. Mol. Cell. 2:275-281.
19. Hennekens, C. H., Dyken, M. L., and Fuster, V. 1997. Aspirin as a therapeutic agent in cardiovascular disease: A statement for health-care professionals from the American Heart Association. Circulation. 96(8):2751-2753.
20. Horne, B., Muhlstein, J., Carlquist, J., Bair, T., Madsen, T., Hart, N., and Anderson, J. 2000. Statin therapy, lipid levels, C-reactive Protein and the survival of patients with angiographically severe coronary artery disease. J. Am. Coll. Cardiol. 36:1774-1780.
21. Jialal, I., Stein D., Balis, D., Grundy, S., Adams-Huet, B., and Devaraj. S. 2001. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 103:1933-1935.
22. Killingsworth, C., Alessandrini, F., Rrishnamurthy, G., Catalan, P., Paulauskis, J., and Godleski, J. 1997. Inflammation, chemokine expression, and death in monocrotaline-treated rats following fuel oil fly ash inhalation. Inhal. Toxicol. 9:541-565.
23. Kushner, I., and Rzewnicki, D. 1999. Acute phase response. In Inflammation: Basic principles and clinical correlates, 3rd ed., pp. 317-329. Baltimore, MD: Lippincott, Williams, Wilkins.
24. Kuta, A., and Baum, L. L. 1986. C-reactive protein in produced by a small number of normal human peripheral blood lymphocytes. J. Exp. Med. 164:321-326.
25. Levinson, S. 2002. What is C-reactive protein telling us about coronary artery disease? Arch. Intern. Med. 162:389-392.
26. Libby, P., Ridker, P., and Maseri, A. 2002. Inflammation and atherosclerosis. Circulation 105:1135-1143.
27. Mattoli, S. 2001. Allergen-induced generation of mediators in the mucosa. Environ. Health Perspect. 109(suppl 4): 553-557.
28. Meier-Ewert, H., Ridker, P., and Rifai, N. 2001. Absence of clinincal diurnal variation of C-reactive protein concentrations in healthy subjects. Clin. Chem. 47:426-430.
29. 10) on the bone marrow. Am. J. Respir. Crit. Care Med. 163:201-209.
30. Ostadal, P., Cepkova, M., and Alan, D. 2000. Atherosclerosis and inflammation. Exp. Clin. Cardiol. 5:87-89.
31. Pasceri, V., Willerson, J., and Yeh, E. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial Cells. Circulation 102:2165-2168.
32. Peters, A., Perz, S., Doring, A., Steinber, J., Koenig, W., and Wichmann, H. 1999. Increases in heart rate during an air pollution episode. Am. J. Epidemiol. 150:1094-1098.
33. Peters, A., Dockery, D., Muller, J., and Mittleman, M. 2001a. Increased paniculate air pollution and the triggering of myocardial infarction. Circulation 103:2810-2815.
34. Peters, A., Frohlich, M., Doring, T, Immervoll, H., Wichmann, W., Hutchinson, M., Pepys, M., and Koenig, W. 2001b. Paniculate air pollution is associated with an acute phase response in men. Eur. Heart J. 22:1198-1204.
35. Pepys, M. 1981. C-reactive protein fifty years on. Lancet 1:653-657.
36. Peyser, P. 1997. Genetic epidemiology of coronary artery disease. Epidemiol. Rev. 19:80-90.
37. Plenge, J., Hernandez, T., Weil, K., Poirier, P., Grunwald, G., Marcovina, S., and Eckel, R. 2002. Simvastatin Lowers C-reactive protein within 14 days. Circulation 106:1447-1452.
38. Pope, C. 2000. Epidemiology of fine paniculate air pollution and human health: Biologic mechanisms and who's at risk? Environ. Health Perspect. 108(suppl. 4):713-723.
39. Pope, A., Verrier, R., Lovett, E., Larson, A., Raizenne, M., Kanner, R., Schwartz, J., Villegas, G., Gold, D., and Dockery, D. 1999. Heart rate variability associated with paniculate air pollution. Ame. Heart J. 138:890-899.
40. Ridker, P., Cushman, M., Stampfer, M., Tracy, R., and Hennekens, C. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:973-979.
41. Ridker, P., Rifai, N., Pfeffer, M., Sacks, F., Moye, L., Goldman, S., Flaker, G., and Braunwald, E. 1998. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 98:839-844.
42. Ridker, P., Hennekens, C., Burnig, J., and Rifai, N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:836-843.
43. Ridker, P., Rifai, N., and Lowenthal, S. 2001a. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 103:1191-1193.
44. Ridker, P., Rifai, N., Clearfeild, M., Downs, J., Weis, S., Miles, and Gotto, A. 2001b. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 344:1959-1965.
45. Rifai, N., and Ridker, P. 2001. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin. Chem. 47:403-411.
46. Seaton, A., MacNess, W., Donaldson, K., and Godden, D. 1995. Particulate air pollution and acute health effects. Lancet 345:176-178.
47. Steel, D., and Whitehead, A. 1994. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15:81-88.
48. Suwa, T., Hogg, J., Quinlan, K., Ohgami, A., Vincent, R., and van Eeden, S. 2002 Paniculate air pollution induces progression of atherosclerosis. J. Am. Coll. Cardiol. 39:935-942.
49. Tan, W., Qui, D., Liam, B., Lee, S., Van Eden, S., D'yachkova, Y., and Hogg, J. 2000. The human bone marrow response to fine paniculate air pollution. Am. J. Crit. Care Med. 161:1213-1217.
50. Tyroler, H. 2000. Coronary heart disease epidemiology in the 21st century. Epidemiol. Rev. 22:7-13.
51. Yeh, T., and Willerson, J. 2003. Coming of age of C-reactive protein. Circulation 107:370.
52. Zimmerman, M., Selzman, C., Cothren, C., Sorensen, A., Raeburn, C., and Harken, A. 2003. Diagnostic implications of C-reactive protein. Arch. Surg. 103:220-224.